Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome
Many patients with irritable bowel syndrome (IBS) are disillusioned by the lack of efficacy of treatments and suffer from numerous symptoms not covered by the Rome criteria for IBS, as the current empirical treatment regimens fail to address these persistent debilitating ‘IBS associated symptoms’. T...
Gespeichert in:
| Veröffentlicht in: | European journal of gastroenterology & hepatology 2005-01, Vol.17 (1), p.21-26 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 26 |
|---|---|
| container_issue | 1 |
| container_start_page | 21 |
| container_title | European journal of gastroenterology & hepatology |
| container_volume | 17 |
| creator | Santelmann, Heiko Howard, John McLaren |
| description | Many patients with irritable bowel syndrome (IBS) are disillusioned by the lack of efficacy of treatments and suffer from numerous symptoms not covered by the Rome criteria for IBS, as the current empirical treatment regimens fail to address these persistent debilitating ‘IBS associated symptoms’. These symptoms are similar to other symptom complexes like chronic fatigue and the so-called ‘candida syndrome’, and many seek help from alternative medicine. The possible role of Candida and yeasts in non-immune compromised individuals is disputed and is the subject of this review. Even if the involvement of yeasts in the aetiology of IBS still remains unclear, there is increasing evidence for yeasts being able to cause IBS-symptoms in sensitized patients via Candida products, antigens and cross-antigens. But more research is needed before antifungal treatment can be recommended as a first line treatment for IBS. |
| doi_str_mv | 10.1097/00042737-200501000-00005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67362081</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67362081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5045-57688269c082907ff5773078251369c70966f3361cadd173cc62dd26d005bc83</originalsourceid><addsrcrecordid>eNp1kc1OxCAUhYnR6Dj6CoaNrqxeSoF2aSb-JZO4mYWuCAU6orQdoc1k3l50Rl25IFwO373kHBDCBK4IVOIaAIpcUJHlAAxIOmZpAdtDE1IImjFein00gYoVGa_I8xE6jvENgAhKxCE6IowXglM2QfbFqjjg1g6q7r3TeBV6M-ohXuLN943qBre0XUyF2UqpjHjVx-hqb_EQ3HJpQ8RNH7ALwaVBSa77tfU4bjoT-taeoING-WhPd_sULe5uF7OHbP50_zi7mWeaQcEyJnhZ5rzSUOYViKZhQlAQZc4ITaqAivOGUk60MiZ50ZrnxuTcJOu1LukUXWzHJhMfo42DbF3U1nvV2X6MkgvKcyhJAsstqEPyEWwjV8G1KmwkAfmVsPxJWP4mLL8TTq1nuzfGurXmr3EXaQLOd4CKWvkmqE67-MfxgjNKvrhiy617P6QA3_24tkG-WuWHV_nfD9NPRZOS4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67362081</pqid></control><display><type>article</type><title>Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome</title><source>Journals@Ovid Complete - AutoHoldings</source><source>MEDLINE</source><creator>Santelmann, Heiko ; Howard, John McLaren</creator><creatorcontrib>Santelmann, Heiko ; Howard, John McLaren</creatorcontrib><description>Many patients with irritable bowel syndrome (IBS) are disillusioned by the lack of efficacy of treatments and suffer from numerous symptoms not covered by the Rome criteria for IBS, as the current empirical treatment regimens fail to address these persistent debilitating ‘IBS associated symptoms’. These symptoms are similar to other symptom complexes like chronic fatigue and the so-called ‘candida syndrome’, and many seek help from alternative medicine. The possible role of Candida and yeasts in non-immune compromised individuals is disputed and is the subject of this review. Even if the involvement of yeasts in the aetiology of IBS still remains unclear, there is increasing evidence for yeasts being able to cause IBS-symptoms in sensitized patients via Candida products, antigens and cross-antigens. But more research is needed before antifungal treatment can be recommended as a first line treatment for IBS.</description><identifier>ISSN: 0954-691X</identifier><identifier>EISSN: 1473-5687</identifier><identifier>DOI: 10.1097/00042737-200501000-00005</identifier><identifier>PMID: 15647635</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins, Inc</publisher><subject>Antigens, Fungal - immunology ; Biological and medical sciences ; Candida - metabolism ; Candidiasis - complications ; Candidiasis - diagnosis ; Candidiasis - therapy ; Diet ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Intestines - microbiology ; Irritable Bowel Syndrome - immunology ; Irritable Bowel Syndrome - microbiology ; Medical sciences ; Other diseases. Semiology ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><ispartof>European journal of gastroenterology & hepatology, 2005-01, Vol.17 (1), p.21-26</ispartof><rights>2005 Lippincott Williams & Wilkins, Inc.</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5045-57688269c082907ff5773078251369c70966f3361cadd173cc62dd26d005bc83</citedby><cites>FETCH-LOGICAL-c5045-57688269c082907ff5773078251369c70966f3361cadd173cc62dd26d005bc83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16465315$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15647635$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Santelmann, Heiko</creatorcontrib><creatorcontrib>Howard, John McLaren</creatorcontrib><title>Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome</title><title>European journal of gastroenterology & hepatology</title><addtitle>Eur J Gastroenterol Hepatol</addtitle><description>Many patients with irritable bowel syndrome (IBS) are disillusioned by the lack of efficacy of treatments and suffer from numerous symptoms not covered by the Rome criteria for IBS, as the current empirical treatment regimens fail to address these persistent debilitating ‘IBS associated symptoms’. These symptoms are similar to other symptom complexes like chronic fatigue and the so-called ‘candida syndrome’, and many seek help from alternative medicine. The possible role of Candida and yeasts in non-immune compromised individuals is disputed and is the subject of this review. Even if the involvement of yeasts in the aetiology of IBS still remains unclear, there is increasing evidence for yeasts being able to cause IBS-symptoms in sensitized patients via Candida products, antigens and cross-antigens. But more research is needed before antifungal treatment can be recommended as a first line treatment for IBS.</description><subject>Antigens, Fungal - immunology</subject><subject>Biological and medical sciences</subject><subject>Candida - metabolism</subject><subject>Candidiasis - complications</subject><subject>Candidiasis - diagnosis</subject><subject>Candidiasis - therapy</subject><subject>Diet</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Intestines - microbiology</subject><subject>Irritable Bowel Syndrome - immunology</subject><subject>Irritable Bowel Syndrome - microbiology</subject><subject>Medical sciences</subject><subject>Other diseases. Semiology</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><issn>0954-691X</issn><issn>1473-5687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1OxCAUhYnR6Dj6CoaNrqxeSoF2aSb-JZO4mYWuCAU6orQdoc1k3l50Rl25IFwO373kHBDCBK4IVOIaAIpcUJHlAAxIOmZpAdtDE1IImjFein00gYoVGa_I8xE6jvENgAhKxCE6IowXglM2QfbFqjjg1g6q7r3TeBV6M-ohXuLN943qBre0XUyF2UqpjHjVx-hqb_EQ3HJpQ8RNH7ALwaVBSa77tfU4bjoT-taeoING-WhPd_sULe5uF7OHbP50_zi7mWeaQcEyJnhZ5rzSUOYViKZhQlAQZc4ITaqAivOGUk60MiZ50ZrnxuTcJOu1LukUXWzHJhMfo42DbF3U1nvV2X6MkgvKcyhJAsstqEPyEWwjV8G1KmwkAfmVsPxJWP4mLL8TTq1nuzfGurXmr3EXaQLOd4CKWvkmqE67-MfxgjNKvrhiy617P6QA3_24tkG-WuWHV_nfD9NPRZOS4A</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>Santelmann, Heiko</creator><creator>Howard, John McLaren</creator><general>Lippincott Williams & Wilkins, Inc</general><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200501</creationdate><title>Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome</title><author>Santelmann, Heiko ; Howard, John McLaren</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5045-57688269c082907ff5773078251369c70966f3361cadd173cc62dd26d005bc83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Antigens, Fungal - immunology</topic><topic>Biological and medical sciences</topic><topic>Candida - metabolism</topic><topic>Candidiasis - complications</topic><topic>Candidiasis - diagnosis</topic><topic>Candidiasis - therapy</topic><topic>Diet</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Intestines - microbiology</topic><topic>Irritable Bowel Syndrome - immunology</topic><topic>Irritable Bowel Syndrome - microbiology</topic><topic>Medical sciences</topic><topic>Other diseases. Semiology</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Santelmann, Heiko</creatorcontrib><creatorcontrib>Howard, John McLaren</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of gastroenterology & hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Santelmann, Heiko</au><au>Howard, John McLaren</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome</atitle><jtitle>European journal of gastroenterology & hepatology</jtitle><addtitle>Eur J Gastroenterol Hepatol</addtitle><date>2005-01</date><risdate>2005</risdate><volume>17</volume><issue>1</issue><spage>21</spage><epage>26</epage><pages>21-26</pages><issn>0954-691X</issn><eissn>1473-5687</eissn><abstract>Many patients with irritable bowel syndrome (IBS) are disillusioned by the lack of efficacy of treatments and suffer from numerous symptoms not covered by the Rome criteria for IBS, as the current empirical treatment regimens fail to address these persistent debilitating ‘IBS associated symptoms’. These symptoms are similar to other symptom complexes like chronic fatigue and the so-called ‘candida syndrome’, and many seek help from alternative medicine. The possible role of Candida and yeasts in non-immune compromised individuals is disputed and is the subject of this review. Even if the involvement of yeasts in the aetiology of IBS still remains unclear, there is increasing evidence for yeasts being able to cause IBS-symptoms in sensitized patients via Candida products, antigens and cross-antigens. But more research is needed before antifungal treatment can be recommended as a first line treatment for IBS.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins, Inc</pub><pmid>15647635</pmid><doi>10.1097/00042737-200501000-00005</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0954-691X |
| ispartof | European journal of gastroenterology & hepatology, 2005-01, Vol.17 (1), p.21-26 |
| issn | 0954-691X 1473-5687 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67362081 |
| source | Journals@Ovid Complete - AutoHoldings; MEDLINE |
| subjects | Antigens, Fungal - immunology Biological and medical sciences Candida - metabolism Candidiasis - complications Candidiasis - diagnosis Candidiasis - therapy Diet Gastroenterology. Liver. Pancreas. Abdomen Humans Intestines - microbiology Irritable Bowel Syndrome - immunology Irritable Bowel Syndrome - microbiology Medical sciences Other diseases. Semiology Stomach. Duodenum. Small intestine. Colon. Rectum. Anus |
| title | Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T06%3A40%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Yeast%20metabolic%20products,%20yeast%20antigens%20and%20yeasts%20as%20possible%20triggers%20for%20irritable%20bowel%20syndrome&rft.jtitle=European%20journal%20of%20gastroenterology%20&%20hepatology&rft.au=Santelmann,%20Heiko&rft.date=2005-01&rft.volume=17&rft.issue=1&rft.spage=21&rft.epage=26&rft.pages=21-26&rft.issn=0954-691X&rft.eissn=1473-5687&rft_id=info:doi/10.1097/00042737-200501000-00005&rft_dat=%3Cproquest_cross%3E67362081%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67362081&rft_id=info:pmid/15647635&rfr_iscdi=true |